Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Calvin Sandra
SVP, CHIEF ACCOUNTING OFFICER at Travere Therapeutics. Filing since 24 Jan 2022.
CIK 0001882909
Company
Date
Role
Action
Shares
Amount
Of holding
TVTX
Travere Therapeutics, Inc.
15 Sep 2026
SVP, CHIEF ACCOUNTING OFFICER
Sold on a plan
5,375
$335.00K
11.3%
TVTX
Travere Therapeutics, Inc.
14 Apr 2026
SVP, CHIEF ACCOUNTING OFFICER
Sold on a plan
21,977
$902.60K
34.2%
TVTX
Travere Therapeutics, Inc.
3 Feb 2026
SVP, CHIEF ACCOUNTING OFFICER
Sold at will
4,333
$139.18K
8.1%
TVTX
Travere Therapeutics, Inc.
24 Dec 2025
SVP, CHIEF ACCOUNTING OFFICER
Sold on a plan
7,402
$296.08K
16.2%
TVTX
Travere Therapeutics, Inc.
15 Dec 2025
SVP, CHIEF ACCOUNTING OFFICER
Sold on a plan
2,910
$104.76K
6.0%
TVTX
Travere Therapeutics, Inc.
4 Nov 2025
SVP, CHIEF ACCOUNTING OFFICER
Sold on a plan
67,115
$2.42M
58.0%
TVTX
Travere Therapeutics, Inc.
11 Feb 2025
SVP, CHIEF ACCOUNTING OFFICER
Sold on a plan
54,244
$1.36M
49.9%
TVTX
Travere Therapeutics, Inc.
3 Feb 2025
SVP, CHIEF ACCOUNTING OFFICER
Sold at will
3,348
$67.36K
5.0%
TVTX
Travere Therapeutics, Inc.
22 Jan 2025
SVP, CHIEF ACCOUNTING OFFICER
Sold at will
925
$17.52K
1.7%
TVTX
Travere Therapeutics, Inc.
26 Dec 2024
SVP, CHIEF ACCOUNTING OFFICER
Sold on a plan
15,000
$258.28K
21.5%
TVTX
Travere Therapeutics, Inc.
25 Nov 2024
SVP, CHIEF ACCOUNTING OFFICER
Sold at will
12,090
$221.26K
18.0%
TVTX
Travere Therapeutics, Inc.
1 Feb 2024
SVP, CHIEF ACCOUNTING OFFICER
Sold at will
2,820
$24.06K
5.1%
TVTX
Travere Therapeutics, Inc.
23 Jan 2024
SVP, CHIEF ACCOUNTING OFFICER
Sold at will
910
$8.25K
2.2%
TVTX
Travere Therapeutics, Inc.
11 May 2023
SVP, Chief Accounting Officer
Sold on a plan
122
$1.97K
0.3%
TVTX
Travere Therapeutics, Inc.
10 May 2023
SVP, Chief Accounting Officer
Sold on a plan
436
$7.23K
1.0%
TVTX
Travere Therapeutics, Inc.
2 Feb 2023
SVP, Chief Accounting Officer
Sold, plan not stated
360
$8.07K
0.8%
TVTX
Travere Therapeutics, Inc.
1 Feb 2023
SVP, Chief Accounting Officer
Sold, plan not stated
1,671
$36.35K
3.7%
TVTX
Travere Therapeutics, Inc.
25 Jan 2023
SVP, Chief Accounting Officer
Sold, plan not stated
192
$4.15K
0.5%
TVTX
Travere Therapeutics, Inc.
24 Jan 2023
SVP, Chief Accounting Officer
Sold, plan not stated
905
$19.82K
2.5%
TVTX
Travere Therapeutics, Inc.
13 Sep 2022
SVP, Chief Accounting Officer
Sold, plan not stated
349
$9.77K
1.0%
TVTX
Travere Therapeutics, Inc.
11 May 2022
SVP, Chief Accounting Officer
Sold, plan not stated
445
$9.76K
1.2%
TVTX
Travere Therapeutics, Inc.
10 May 2022
SVP, Chief Accounting Officer
Sold, plan not stated
436
$9.38K
1.2%
TVTX
Travere Therapeutics, Inc.
31 Jan 2022
VP, Corp Controller and CAO
Sold, plan not stated
798
$21.15K
2.1%
TVTX
Travere Therapeutics, Inc.
24 Jan 2022
VP, Corp Controller and CAO
Sold, plan not stated
934
$22.95K
3.2%
24 decisions on file.
